|
🐢
|
Choosing the right cell line for breast cancer research
D. Holliday,
V. Speirs
|
10 |
2011 |
10
🐢
|
|
🦁
|
Matrix metalloproteinases and angiogenesis
V. Speirs
|
8 |
2000 |
8
🦁
|
|
🐜
|
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
20 auth.
M. Dowsett,
C. Allred,
Jill Knox,
E. Quinn,
J. Salter,
C. Wale,
J. Cuzick,
J. Houghton,
N. Williams,
E. Mallon,
...
H. Bishop,
I. Ellis,
D. Larsimont,
H. Sasano,
P. Carder,
A. Cussac,
F. Knox,
V. Speirs,
J. Forbes,
A. Buzdar
|
8 |
2008 |
8
🐜
|
|
🐜
|
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer
88 auth.
S. Eccles,
E. Aboagye,
Simak Ali,
A. Anderson,
J. Armes,
F. Berditchevski,
J. Blaydes,
K. Brennan,
N. Brown,
H. Bryant,
N. Bundred,
J. Burchell,
A. Campbell,
J. Carroll,
R. Clarke,
...
C. Coles,
G. Cook,
A. Cox,
N. Curtin,
L. Dekker,
I. Dos,
Santos Silva,
S. Duffy,
D. Easton,
D. Eccles,
D. Edwards,
J. Edwards,
G. Evans,
D. Fenlon,
J. Flanagan,
C. Foster,
W. Gallagher,
M. García-Closas,
J. Gee,
A. Gescher,
V. Goh,
A. Groves,
A. Harvey,
M. Harvie,
B. Hennessy,
S. Hiscox,
I. Holen,
S. Howell,
A. Howell,
G. Hubbard,
N. Hulbert-Williams,
M. Hunter,
B. Jasani,
L. Jones,
T. Key,
C. Kirwan,
A. Kong,
I. Kunkler,
S. Langdon,
M. Leach,
D. Mann,
J. Marshall,
L. Martin,
Stewart G. Martin,
J. Macdougall,
D. Miles,
W. Miller,
Joanna R. Morris,
S. Moss,
P. Mullan,
R. Natrajan,
J. O. Connor,
R. O. Connor,
C. Palmieri,
P. Pharoah,
E. Rakha,
E. Reed,
S. Robinson,
E. Sahai,
J. Saxton,
P. Schmid,
M. Smalley,
V. Speirs,
R. Stein,
J. Stingl,
C. Streuli,
A. Tutt,
G. Velikova,
R. Walker,
C. Watson,
K. Williams,
L. Young,
A. Thompson
|
8 |
2013 |
8
🐜
|
|
🐢
|
Breast cancer cell lines: friend or foe?
S. Burdall,
A. Hanby,
M. Lansdown,
V. Speirs
|
8 |
2003 |
8
🐢
|
|
🦁
|
Increased expression of estrogen receptor beta mRNA in tamoxifen-resistant breast cancer patients.
V. Speirs,
C. Malone,
D. Walton,
M. Kerin,
Stephen L. Atkin
|
8 |
1999 |
8
🦁
|
|
🦁
|
Coexpression of Estrogen Receptor α and β: Poor Prognostic Factors in Human Breast Cancer?
7 auth.
V. Speirs,
A. Parkes,
M. Kerin,
D. Walton,
P. J. Carleton,
J. Fox,
...
S. Atkin
|
7 |
1999 |
7
🦁
|
|
🐢
|
Reduced expression of oestrogen receptor β in invasive breast cancer and its re‐expression using DNA methyl transferase inhibitors in a cell line model
11 auth.
G. Skliris,
K. Munot,
S. Bell,
P. Carder,
S. Lane,
K. Horgan,
...
M. Lansdown,
A. Parkes,
A. Hanby,
A. Markham,
V. Speirs
|
7 |
2003 |
7
🐢
|
|
🐢
|
Phyto-oestrogens and breast cancer chemoprevention
J. Limer,
V. Speirs
|
7 |
2004 |
7
🐢
|
|
🐢
|
Nuclear and Cytoplasmic Expression of ERβ1, ERβ2, and ERβ5 Identifies Distinct Prognostic Outcome for Breast Cancer Patients
12 auth.
A. Shaaban,
A. Green,
S. Karthik,
Yalda Alizadeh,
T. Hughes,
L. Harkins,
...
I. Ellis,
J. Robertson,
E. Paish,
P. Saunders,
N. Groome,
V. Speirs
|
7 |
2008 |
7
🐢
|
|
🦁
|
The rising incidence of male breast cancer
V. Speirs,
A. Shaaban
|
7 |
2009 |
7
🦁
|
|
🐢
|
Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: Identification of interleukin‐8 as a potential regulatory factor in breast tumours
A. Green,
V. Green,
M. White,
V. Speirs
|
7 |
1997 |
7
🐢
|
